Stablepharma Board Announcements

Following the outstanding success of our recent £1.35m equity raise, StablePharma ( is bringing a patented device to market that stands to significantly improve the way most vaccines are distributed globally, which will eliminate the current c. 50% wastage. Now, that we have our first clinical trials in humans underway, Stablepharma is delighted to announce […]

Read More